1. Home
  2. IPSC vs MAXN Comparison

IPSC vs MAXN Comparison

Compare IPSC & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • MAXN
  • Stock Information
  • Founded
  • IPSC 2019
  • MAXN 2019
  • Country
  • IPSC United States
  • MAXN Singapore
  • Employees
  • IPSC N/A
  • MAXN N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • MAXN Semiconductors
  • Sector
  • IPSC Health Care
  • MAXN Technology
  • Exchange
  • IPSC Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • IPSC 58.1M
  • MAXN 61.7M
  • IPO Year
  • IPSC 2021
  • MAXN N/A
  • Fundamental
  • Price
  • IPSC $0.54
  • MAXN $2.86
  • Analyst Decision
  • IPSC Strong Buy
  • MAXN Sell
  • Analyst Count
  • IPSC 5
  • MAXN 6
  • Target Price
  • IPSC $3.67
  • MAXN $195.80
  • AVG Volume (30 Days)
  • IPSC 551.0K
  • MAXN 170.3K
  • Earning Date
  • IPSC 05-08-2025
  • MAXN 05-29-2025
  • Dividend Yield
  • IPSC N/A
  • MAXN N/A
  • EPS Growth
  • IPSC N/A
  • MAXN N/A
  • EPS
  • IPSC N/A
  • MAXN N/A
  • Revenue
  • IPSC $6,589,000.00
  • MAXN $689,010,000.00
  • Revenue This Year
  • IPSC $833.10
  • MAXN N/A
  • Revenue Next Year
  • IPSC N/A
  • MAXN $34.68
  • P/E Ratio
  • IPSC N/A
  • MAXN N/A
  • Revenue Growth
  • IPSC 194.81
  • MAXN N/A
  • 52 Week Low
  • IPSC $0.34
  • MAXN $2.49
  • 52 Week High
  • IPSC $3.70
  • MAXN $410.00
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 53.48
  • MAXN 40.90
  • Support Level
  • IPSC $0.34
  • MAXN $2.68
  • Resistance Level
  • IPSC $0.54
  • MAXN $3.35
  • Average True Range (ATR)
  • IPSC 0.05
  • MAXN 0.33
  • MACD
  • IPSC 0.02
  • MAXN 0.05
  • Stochastic Oscillator
  • IPSC 93.95
  • MAXN 43.07

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: